Abstract:Background and Aims Alcohol consumption is a well‐established risk factor for the onset and progression of hepatic steatosis. Perilipin 5 (Plin5), a lipid droplet protein, is an important protective factor against hepatic lipotoxicity induced by excessive lipolysis, but its role and molecular mechanism in alcoholic liver disease (ALD) are not fully elucidated. Methods The optimized National Institute on Alcohol Abuse and Alcoholism model was used to construct ALD model mice. Automatic biochemical analyser was used for Biochemical Parameters. The primary hepatocytes and Plin5‐overexpressed HepG2 cells (including full‐length Plin5 and Plin5 deleting 444–464 aa) were used for in vitro experiment. Haematoxylin and Eosin staining, Oil Red O staining, Bodipy 493/503 staining, Periodic Acid‐Schiff staining, immunohistochemistry and JC‐1 staining were used to evaluate cell morphology, lipids, glycogen, inflammation and membrane potential. Commercially kits are used to detect glycolipid metabolites, such as triglycerides, glycogen, glucose, reactive oxygen species, lactic acids, ketone bodies. Fluorescently labelled deoxyglucose, NBDG, was used for glucose intake. An XF96 extracellular flux analyser was used to determinate oxygen consumption rate in hepatocytes. The morphological and structural damage of mitochondria was evaluated by electron microscopy. Classical ultracentrifugation is used to separate the subcellular organelles of tissues and cells. Immunoblotting and qPCR were used to detect changes in mRNA and protein levels of related genes. Results Our results showed that the expression of Plin5 in mouse livers was enhanced by alcohol intake, and Plin5 deficiency aggravated the alcohol‐induced liver injury. To clarify the mechanism, we found that Plin5 deficiency significantly elevated the hepatic NADH levels and ketone body production in the alcohol‐treated mice. As NADH elevation could promote the reduction of pyruvate into lactate and then inhibit the gluconeogenesis, alcohol‐treated Plin5‐deficient mice exhibited more lactate production and severer hypoglycemia. These results implied that Plin5 deficiency impaired the mitochondrial oxidative functions in the presence of alcohol. In addition, we demonstrated that Plin5 could be recruited onto mitochondria by alcohol, while Plin5 without mitochondrial targeting sequences lost its mitochondrial protection functions. Conclusion Collectively, this study demonstrated that the mitochondrial Plin5 could protect the alcohol‐induced mitochondrial injury, which provides an important new insight on the roles of Plin5 in highly oxidative tissues.

Perilipin5 Protects Against Non-Alcoholic Steatohepatitis by Increasing 11-Dodecenoic Acid and Inhibiting the Occurrence of Ferroptosis.

Perilipin 5 Improves Hepatic Lipotoxicity by Inhibiting Lipolysis.

Perilipin 5 deletion protects against nonalcoholic fatty liver disease and hepatocellular carcinoma by modulating lipid metabolism and inflammatory responses

Perilipin 5 Protects against Cellular Oxidative Stress by Enhancing Mitochondrial Function in HepG2 Cells

Effects of perilipin 2 antisense oligonucleotide treatment on hepatic lipid metabolism and gene expression.

Perilipin 5 protects the mitochondrial oxidative functions and improves the alcoholic liver injury in mice

Knockdown of hepatocyte Perilipin-3 mitigates hepatic steatosis and steatohepatitis caused by hepatocyte CGI-58 deletion in mice

Plin5 alleviates myocardial ischaemia/reperfusion injury by reducing oxidative stress through inhibiting the lipolysis of lipid droplets

Hepatic Perilipin 5 Promotes Lipophagy and Alters Lipid Droplet and Mitochondrial Dynamics

PLIN5 Suppresses Lipotoxicity and Ferroptosis in Cardiomyocyte via Modulating PIR/NF-κB Axis

Perilipin 5 Reduces Oxidative Damage Associated With Lipotoxicity by Activating the PI3K/ERK-Mediated Nrf2-ARE Signaling Pathway in INS-1 Pancreatic β-Cells.

Perilipin 5 Reduces Oxidative Damage Associated With Lipotoxicity by Activating the PI3K/ERK-Mediated Nrf2-ARE Signaling Pathway in INS-1 Pancreatic -Cells

Hepatic PLIN5 Signals Via SIRT1 to Promote Autophagy and Prevent Inflammation During Fasting

Plin5 Bidirectionally Regulates Lipid Metabolism in Oxidative Tissues

Spontaneous Development of Hepatosteatosis in Perilipin-1 Null Mice with Adipose Tissue Dysfunction.

Perilipin 5 deficiency aggravates cardiac hypertrophy by stimulating lactate production in leptin-deficient mice

Peroxisome Proliferator-Activated Receptor Γ Coactivator 1α Maintains NAD+ Bioavailability Protecting Against Steatohepatitis

Plin5 Deficiency Exacerbates Pressure Overload-Induced Cardiac Hypertrophy and Heart Failure by Enhancing Myocardial Fatty Acid Oxidation and Oxidative Stress.

Ferroptosis inhibitor liproxstatin-1 alleviates metabolic dysfunction-associated fatty liver disease in mice: potential involvement of PANoptosis

Plin3 protects against alcoholic liver injury by facilitating lipid export from the endoplasmic reticulum.

Neutralization of Oxidized Phospholipids Ameliorates Non-alcoholic Steatohepatitis